Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS other · 2025-05-08

Clinical Trial Update: Aspirin 150 mg vs 100 mg for Prevention of Preeclampsia in High-Risk Obese Pregnant Women [Phase 3]

View source ↗

Summary

Phase 3 trial comparing aspirin 150 mg versus 100 mg for prevention of preeclampsia in high-risk obese pregnant women; study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Aspirin (Aspirin)

Snippet

Sponsor: FANG HE | Conditions: Preeclampsia | Phase 3 | Status: NOT_YET_RECRUITING